News Focus
News Focus
icon url

Jonjones325

10/16/22 10:05 AM

#378075 RE: Jonjones325 #378068

It’s either going to be a blessing or a curse that our first biggest true test is the most difficult.

It is the test that all our other indications will be judged and assigned promise, probability, value, etc.

We’ve been throwing powerful words around for years: homeostasis, prophylactic, reverse, less dementia, upstream, gene pathways, etc…

Will all these words will be just words or will they carry weight? If our trial isn’t that great, we go back to trying to prove these words have meaning for our “platform”.

All those potential indications floating around the brain will be that much further out of reach in the minds of investors.

Moment of truth is here. Exciting and scary. For me at least.
icon url

plexrec

10/16/22 11:16 AM

#378084 RE: Jonjones325 #378068

So Jonjones-"PR if you have the goods."--do we have the goods ?? What do you think ???
icon url

tradeherpete

10/16/22 12:30 PM

#378093 RE: Jonjones325 #378068

The non transparent, close to the vest, calendar challenged CEO is about to bare all.

Who’s not going to show up for that?

Who will attend the TLD presentation of little unknown Anavex with a novel MOA if no excitement is drummed up?


I do share your desire for desire for a TLD PR in about 18 and a half hours.